It addresses T cell exhaustion in HCC, uncovering the role of inhibitory molecules such as PD-1 and LAG-3, and proposes potential targets, such as blocking PD-1 and IL-35, for enhancing γδ T cell function. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.